Results 211 to 220 of about 36,038 (221)

Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment

Digestive and Liver Disease, 2010
L Marzio
exaly  

Green RP-HPLC method for simultaneous determination of moxifloxacin combinations: Investigation of the greenness for the proposed method

Microchemical Journal, 2019
Mona Fathy, Fawzia Ibrahim, Heba Elmansi   +2 more
exaly  

Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections

International Journal of Antimicrobial Agents, 2002
Rosario Musumeci, G Blandino, A Speciale   +2 more
exaly  

Moxifloxacin is an effective and safe candidate agent for tuberculosis treatment: a meta-analysis

International Journal of Infectious Diseases, 2017
exaly  

Moxifloxacin

Reactions Weekly, 2004
openaire   +1 more source

Moxifloxacin-resistant and moxifloxacin-susceptible Staphylococcus aureus Keratitis: Outcomes from a 10-year retrospective study

Ocular Surface
Rohan Bir Singh, Vishal Jhanji, Robert Shanks   +2 more
exaly  

QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome

British Journal of Pharmacology, 2005
exaly  

Moxifloxacin

Reactions Weekly, 2012
openaire   +1 more source

Moxifloxacin 0.5% Ophthalmic Solution

Drugs, 2012
exaly  

Moxifloxacin

Reactions Weekly, 2005
openaire   +1 more source